Mark G. Bock
108Patents
20h-index
133Co-inventors
93Inventor score
Filing activity: Jan 9, 1978 → Oct 17, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4820834A | Benzodiazepine analogs | Human Necessities | 114 | Expired |
| US5324726A | Benzodiazepine analogs | Human Necessities | 90 | Expired |
| US5464788A | Tocolytic oxytocin receptor antagonists | Chemistry; Metallurgy | 78 | Expired |
| US5756504A | Tocolytic oxytocin receptor antagonists | Chemistry; Metallurgy | 58 | Expired |
| US4309430A | Pyrazinyl-1,2,4-oxadiazole-5-ones, for treatment of edema, and processes for preparing same | Human Necessities | 53 | Expired |
| US5206234A | Benzolactam analogs as antagonists of CCK | Human Necessities | 46 | Expired |
| US4755508A | Benzodiazepine analogs and use as antogonists of gastrin and cholecystokinin | Chemistry; Metallurgy | 45 | Expired |
| US5004741A | Methods of antagonizing CCK or gastrin with benzodiazepine analogs | Human Necessities | 43 | Expired |
| US5665719A | Benzoxazinone and benzopyrimidinone piperidinyl tocolytic oxytocin receptor antagonists | Chemistry; Metallurgy | 40 | Expired |
| US5166151A | 2-Benzazepines with 5- and 6-membered heterocyclic rings, compositions and medical methods of use thereof | Chemistry; Metallurgy | 36 | Expired |
| US4145551A | Pyrazine-2-carbonyloxyguanidines | Chemistry; Metallurgy | 35 | Expired |
| US5220017A | Cholecystokinin antagonists | Human Necessities | 34 | Expired |
| US4362724A | Method of treating edema and hypertension and pharmaceutical composition therefor in which the active ingredient comprises a novel substituted pyrazinyl-1,2,4-oxadiazole and a kaliuretic diuretic | Chemistry; Metallurgy | 34 | Expired |
| US5597915A | Benzodiazepine derivatives, compositions containing them and their use in therapy | Human Necessities | 31 | Expired |
| US5177071A | 1,4-benzodiazepines with 6-membered heterocyclic rings to treat panic and anxiety disorder | Human Necessities | 31 | Expired |
| US4479941A | Renin inhibitory peptides having PHE.sup.13 delection | Emerging Cross-Sectional Technologies | 30 | Expired |
| US5175159A | 3-substituted-1,4-benzodiazepines as oxytocin antagonists | Chemistry; Metallurgy | 27 | Expired |
| US4812442A | Tripeptide renin inhibitors | Emerging Cross-Sectional Technologies | 22 | Expired |
| US5210082A | 2-benzazepines with 5- and 6-membered heterocyclic rings to treat pain and anxiety disorders | Human Necessities | 20 | Expired |
| US4309540A | Substituted pyrazinyl-1,2,4-oxadiazoles | Human Necessities | 20 | Expired |
| US5185331A | Triazolobenzodiazepines | Human Necessities | 20 | Expired |
| US4454132A | Pharmaceutical compositions of novel substituted pyrazinyl-1,2,4-oxadiazoles useful in the treatment of edema and hypertension | Chemistry; Metallurgy | 20 | Expired |
| US5834464A | Imidazolinobenzodiazepines | Chemistry; Metallurgy | 18 | Expired |
| US4554272A | Substituted quinazolino-1,4-benzodiazepin-6,9-diones and their preparation | Emerging Cross-Sectional Technologies | 17 | Expired |
| US5220018A | Cholecystokinin antagonists | Chemistry; Metallurgy | 17 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.